Literature DB >> 6830778

Subcellular localisation of leucine aminopeptidase in human polymorphonuclear leukocytes.

G P Smith, R R MacGregor, T J Peters.   

Abstract

Human polymorphonuclear leukocytes were homogenised in isotonic sucrose and subjected to analytical subcellular fractionation by sucrose density gradient centrifugation. The gradient fractions were assayed for leucine aminopeptidase and for principal organelle marker enzymes. Leucine aminopeptidase, when assayed with both L-leucine-7-amido-4-methyl-coumarin and leucyl-2-naphthylamide as substrate, showed a unimodal distribution with an equilibrium density of 1.18 g X cm-3. This distribution was quite distinct from that exhibited by marker enzymes for all the recognized subcellular organelles: there was no leucine aminopeptidase associated with the plasma membrane. Fractionation experiments with neutrophils treated with isotonic sucrose containing a low concentration of digitonin, and studies with the non-permeant ectoenzyme inhibitor, diazotised sulphanilic acid, confirmed that leucine aminopeptidase had a purely intracellular localisation. Fractionation experiments with neutrophils homogenised in sucrose medium containing digitonin, showed leucine aminopeptidase associated with a membrane fraction. It is suggested that leucine aminopeptidase is located to the membrane of a previously unrecognised population of cytoplasmic granules of the human neutrophil.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6830778     DOI: 10.1016/0005-2736(83)90475-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Ca2+ inhibition of brush border alkaline phosphatase activity in Hymenolepis diminuta.

Authors:  J B Hipkiss; C J Branford White
Journal:  Z Parasitenkd       Date:  1985

2.  CD13/aminopeptidase N in collagen vascular diseases.

Authors:  Hirohumi Dan; Kenji Tani; Kayoko Hase; Teruki Shimizu; Hiroyuki Tamiya; Yanjmaa Biraa; Luping Huang; Hiroaki Yanagawa; Saburo Sone
Journal:  Rheumatol Int       Date:  2003-09-12       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.